Arcutis Biotherapeutics, Inc. — SC 13D/A Filings
15 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Arcutis Biotherapeutics, Inc. (ARQT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Arcutis Biotherapeutics, Inc. has filed 15 SC 13D/A documents with the SEC since 2019. To view all SEC filings by Arcutis Biotherapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | SC 13D/A | 0001193125-24-060422 | Mar 6, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-264081 | Oct 26, 2023 | — |
| SC 13D/A | AMENDMENT NO. 6 | 0000947871-22-000936 | Aug 26, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-216042 | Aug 9, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-214960 | Aug 8, 2022 | — |
| SC 13D/A | AMENDMENT NO. 5 | 0000947871-22-000835 | Aug 8, 2022 | — |
| SC 13D/A | AMENDMENT NO. 4 | 0000947871-22-000726 | Jun 28, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-162372 | May 27, 2022 | — |
| SC 13D/A | AMENDMENT NO. 3 | 0000947871-22-000449 | Apr 8, 2022 | — |
| SC 13D/A | AMENDMENT NO. 3 TO SCHEDULE 13D | 0001193125-21-159339 | May 12, 2021 | — |
| SC 13D/A | AMENDMENT NO. 2 TO SCHEDULE 13D | 0001193125-21-033691 | Feb 9, 2021 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000947871-21-000140 | Feb 9, 2021 | — |
| SC 13D/A | SC 13D/A | 0001193125-21-032458 | Feb 8, 2021 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-20-000786 | Oct 7, 2020 | — |
| SC 13D/A | AMENDMENT NO. 1 TO SCHEDULE 13D | 0001193125-20-264634 | Oct 6, 2020 | — |